AmpFire® HPV High Risk Genotyping
Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68.
Fast. Simple. Accurate.
Special Features:
- Method:
- Isothermal amplification with real time fluorescence detection
- Simplicity:
- Extremely simple sample processing - no DNA purification needed
- Limited hands-on time
- Fast:
- Sample-to-result in less than 1.5 hours*
- Accurate:
- High accuracy and sensitivity with all necessary controls
- Flexible:
- Suitable for different sample types
- Flexible sample numbers per run with no waste of reagents
* depending on sample type. For FFPE samples: time to results approx. 160 minutes
Product number 80736
Click here to navigate
- Details
- Conditions of sale
- Documentation
- Insights
- FAQ
- Related products
-
Details
Technical Specifications:
- Sample types:
- Dry swab samples, Cervical samples stored in ThinPrep® (PreservCyt Solution), SurePathTM, FFPE biopsy, or purified DNA samples.
- Target region:
- Various regions in the viral genome including E6/E7
- Reaction volume:
- 25 µL
- Reaction time:
- Approx. 90 minutes including sample processing*
- Equipment:
- Heating block and real-time PCR system (compatible with CFX96 - Bio-Rad, ABI7500 - Thermo Fisher Scientific, Rotor-Gene Q - QIAGEN, PowerGene 9600 - Atila PCR system, and other RT-PCR systems with 5 fluorescence channels)
AmpFire is a registered trademark of Atila Biosystems Ltd., Thinprep is a registered trademark of Hologic Inc., Surepath is a registered trademark of Becton, Dickinson and Company.
- Sample types:
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all product documentation right away.
Other documents
FileISO13485_Atila_UQ-13951.pdf (pdf, 483.46 kb)Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
May 3, 2024EUROGIN 2024 – key takeaway messages
The annual EUROGIN conference covers a dense scientific program on the topic of Human papillomavirus (HPV) and its associated cancers, always with a...
May 2, 2024Scientific poster – Inter- and intra-laboratory reproducibility of the AmpFire® HPV Screening 16/18/HR assay
This poster summarizes the investigation of the reproducibility (within a laboratory and between laboratories) of the AmpFire HPV Screening 16/18/HR...
Nov 6, 2023A risk-based approach for post-treatment detection of recurrent CIN
This article describes how HPV genotyping and DNA methylation analysis can help discriminate women in need of re-treatment from those who can be...
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products